BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Song X, Guo Y, Lang X, Li Z, Zhang XY. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology 2021;124:105061. [PMID: 33291004 DOI: 10.1016/j.psyneuen.2020.105061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Çevik Durmaz Y, Menekli T, Ersoy Özcan B. The Effects of Hopelessness and Some Variables on Metabolic Syndrome in Schizophrenia Patients. Clin Nurs Res 2021;:10547738211057237. [PMID: 34930066 DOI: 10.1177/10547738211057237] [Reference Citation Analysis]
2 Zhuo C, Xu Y, Wang H, Zhou C, Liu J, Yu X, Shao H, Tian H, Fang T, Li Q, Chen J, Xu S, Ma X, Yang W, Yao C, Li B, Yang A, Chen Y, Huang G, Lin C. Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia. J Affect Disord 2021;295:163-72. [PMID: 34464878 DOI: 10.1016/j.jad.2021.08.023] [Reference Citation Analysis]
3 Liu H, Zhu Y, Wu X, He K, Wang X, Sun P, Zhao J, Yao Y, Ren J, Mao R, Yang T, Yang L, Sun X, Jiang P, Zhang C, Fang Y. Comorbidity and Treatment in Older Psychiatric In-patients-A Retrospective Study in a Chinese Psychiatric Hospital. Front Psychiatry 2021;12:722329. [PMID: 34764894 DOI: 10.3389/fpsyt.2021.722329] [Reference Citation Analysis]
4 Lang X, Liu Q, Fang H, Zhou Y, Forster MT, Li Z, Zhang X. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia. Psychopharmacology (Berl) 2021;238:3643-52. [PMID: 34586464 DOI: 10.1007/s00213-021-05983-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Seeman MV, González-Rodríguez A. Stratification by Sex and Hormone Level When Contrasting Men and Women in Schizophrenia Trials Will Improve Personalized Treatment. J Pers Med 2021;11:929. [PMID: 34575706 DOI: 10.3390/jpm11090929] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shen H, Zhang L, Li Y, Zheng D, Du L, Xu F, Xu C, Liu Y, Shen J, Li Z, Cui D. Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study. Psychol Med . [DOI: 10.1017/s0033291721002944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Q, He H, Bai X, Jiang L, Chen W, Zeng X, Li Y, Teixeira AL, Dai J. Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese. Front Psychiatry 2021;12:702720. [PMID: 34305687 DOI: 10.3389/fpsyt.2021.702720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lang X, Zhou Y, Zhao L, Gu Y, Wu X, Zhao Y, Li Z, Zhang X. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients. Psychoneuroendocrinology 2021;132:105344. [PMID: 34274733 DOI: 10.1016/j.psyneuen.2021.105344] [Reference Citation Analysis]
10 Li Z, Wang S, Chen Y, Wu X, Gu Y, Lang X, Wu F, Zhang XY. Smoking affects the patterns of metabolic disorders and metabolic syndrome in patients with first-episode drug-naive schizophrenia - a large sample study based on Chinese Han population. Int J Neuropsychopharmacol 2021:pyab038. [PMID: 34153098 DOI: 10.1093/ijnp/pyab038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]